Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions.

Apoptosis : an international journal on programmed cell death

Gandesiri M, Chakilam S, Ivanovska J, Benderska N, Ocker M, Di Fazio P, Feoktistova M, Gali-Muhtasib H, Rave-Fränk M, Prante O, Christiansen H, Leverkus M, Hartmann A, Schneider-Stock R.
PMID: 26960313
Apoptosis. 2016 May;21(5):671-4. doi: 10.1007/s10495-016-1224-7.

No abstract available.

Cite
Gandesiri M, Chakilam S, Ivanovska J, et al. Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions. Apoptosis. 2016;21(5):671-4doi: 10.1007/s10495-016-1224-7.
Gandesiri, M., Chakilam, S., Ivanovska, J., Benderska, N., Ocker, M., Di Fazio, P., Feoktistova, M., Gali-Muhtasib, H., Rave-Fränk, M., Prante, O., Christiansen, H., Leverkus, M., Hartmann, A., & Schneider-Stock, R. (2016). Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions. Apoptosis : an international journal on programmed cell death, 21(5), 671-4. https://doi.org/10.1007/s10495-016-1224-7
Gandesiri, Muktheshwar, et al. "Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions." Apoptosis : an international journal on programmed cell death vol. 21,5 (2016): 671-4. doi: https://doi.org/10.1007/s10495-016-1224-7
Gandesiri M, Chakilam S, Ivanovska J, Benderska N, Ocker M, Di Fazio P, Feoktistova M, Gali-Muhtasib H, Rave-Fränk M, Prante O, Christiansen H, Leverkus M, Hartmann A, Schneider-Stock R. Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions. Apoptosis. 2016 May;21(5):671-4. doi: 10.1007/s10495-016-1224-7. PMID: 26960313.
Copy Download .nbib Format: NLM
Erratum to 'Deep hypothermic circulatory arrest or tepid regional cerebral perfusion: impact on haemodynamics and myocardial integrity in a randomized experimental trial' [Interact CardioVasc Thorac Surg 2018;26:667-672].

Interactive cardiovascular and thoracic surgery

Kellermann S, Janssen C, Münch F, Koch A, Schneider-Stock R, Cesnjevar RA, Rüffer A.
PMID: 29596696
Interact Cardiovasc Thorac Surg. 2018 Apr 01;26(4):715. doi: 10.1093/icvts/ivy116.

No abstract available.

Cite
Kellermann S, Janssen C, Münch F, et al. Erratum to 'Deep hypothermic circulatory arrest or tepid regional cerebral perfusion: impact on haemodynamics and myocardial integrity in a randomized experimental trial' [Interact CardioVasc Thorac Surg 2018;26:667-672]. Interact Cardiovasc Thorac Surg. 2018;26(4):715doi: 10.1093/icvts/ivy116.
Kellermann, S., Janssen, C., Münch, F., Koch, A., Schneider-Stock, R., Cesnjevar, R. A., & Rüffer, A. (2018). Erratum to 'Deep hypothermic circulatory arrest or tepid regional cerebral perfusion: impact on haemodynamics and myocardial integrity in a randomized experimental trial' [Interact CardioVasc Thorac Surg 2018;26:667-672]. Interactive cardiovascular and thoracic surgery, 26(4), 715. https://doi.org/10.1093/icvts/ivy116
Kellermann, Stephanie, et al. "Erratum to 'Deep hypothermic circulatory arrest or tepid regional cerebral perfusion: impact on haemodynamics and myocardial integrity in a randomized experimental trial' [Interact CardioVasc Thorac Surg 2018;26:667-672]." Interactive cardiovascular and thoracic surgery vol. 26,4 (2018): 715. doi: https://doi.org/10.1093/icvts/ivy116
Kellermann S, Janssen C, Münch F, Koch A, Schneider-Stock R, Cesnjevar RA, Rüffer A. Erratum to 'Deep hypothermic circulatory arrest or tepid regional cerebral perfusion: impact on haemodynamics and myocardial integrity in a randomized experimental trial' [Interact CardioVasc Thorac Surg 2018;26:667-672]. Interact Cardiovasc Thorac Surg. 2018 Apr 01;26(4):715. doi: 10.1093/icvts/ivy116. PMID: 29596696.
Copy Download .nbib Format: NLM
Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes.

International journal of molecular sciences

Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, Schneider-Stock R, Geppert CI.
PMID: 34884913
Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313108.

Peritumoral budding and intratumoral budding (ITB) are important prognostic factors for colorectal cancer patients. Scientists worldwide have investigated the role of budding in tumor progression and its prognosis, but guidelines for reliably identifying tumor buds based on morphology are...

Cite
Pour Farid P, Eckstein M, Merkel S, et al. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313108.
Pour Farid, P., Eckstein, M., Merkel, S., Grützmann, R., Hartmann, A., Bruns, V., Benz, M., Schneider-Stock, R., & Geppert, C. I. (2021). Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313108
Pour Farid, Pantea, et al. "Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313108
Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, Schneider-Stock R, Geppert CI. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313108. PMID: 34884913.
Copy Download .nbib Format: NLM
Corrigendum: Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer.

ChemMedChem

Fröhlich T, Ndreshkjana B, Muenzner JK, Reiter C, Hofmeister E, Mederer S, Fatfat M, El-Baba C, Gali-Muhtasib H, Schneider-Stock R, Tsogoeva SB.
PMID: 33956398
ChemMedChem. 2021 May 06;16(9):1513. doi: 10.1002/cmdc.202100088. Epub 2021 Apr 06.

No abstract available.

Cite
Fröhlich T, Ndreshkjana B, Muenzner JK, et al. Corrigendum: Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer. ChemMedChem. 2021;16(9):1513doi: 10.1002/cmdc.202100088.
Fröhlich, T., Ndreshkjana, B., Muenzner, J. K., Reiter, C., Hofmeister, E., Mederer, S., Fatfat, M., El-Baba, C., Gali-Muhtasib, H., Schneider-Stock, R., & Tsogoeva, S. B. (2021). Corrigendum: Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer. ChemMedChem, 16(9), 1513. https://doi.org/10.1002/cmdc.202100088
Fröhlich, Tony, et al. "Corrigendum: Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer." ChemMedChem vol. 16,9 (2021): 1513. doi: https://doi.org/10.1002/cmdc.202100088
Fröhlich T, Ndreshkjana B, Muenzner JK, Reiter C, Hofmeister E, Mederer S, Fatfat M, El-Baba C, Gali-Muhtasib H, Schneider-Stock R, Tsogoeva SB. Corrigendum: Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer. ChemMedChem. 2021 May 06;16(9):1513. doi: 10.1002/cmdc.202100088. Epub 2021 Apr 06. PMID: 33956398.
Copy Download .nbib Format: NLM
A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.

Cancers

Bueno-Fortes S, Muenzner JK, Berral-Gonzalez A, Hampel C, Lindner P, Berninger A, Huebner K, Kunze P, Bäuerle T, Erlenbach-Wuensch K, Sánchez-Santos JM, Hartmann A, De Las Rivas J, Schneider-Stock R.
PMID: 35008299
Cancers (Basel). 2021 Dec 28;14(1). doi: 10.3390/cancers14010136.

The epithelial-mesenchymal transition (EMT) is associated with tumor aggressiveness and increased invasion, migration, metastasis, angiogenesis, and drug resistance. Although the HCT116 p21-/- cell line is well known for its EMT-associated phenotype, with high Vimentin and low E-cadherin protein levels,...

Cite
Bueno-Fortes S, Muenzner JK, Berral-Gonzalez A, et al. A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010136.
Bueno-Fortes, S., Muenzner, J. K., Berral-Gonzalez, A., Hampel, C., Lindner, P., Berninger, A., Huebner, K., Kunze, P., Bäuerle, T., Erlenbach-Wuensch, K., Sánchez-Santos, J. M., Hartmann, A., De Las Rivas, J., & Schneider-Stock, R. (2021). A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer. Cancers, 14(1), . https://doi.org/10.3390/cancers14010136
Bueno-Fortes, Santiago, et al. "A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010136
Bueno-Fortes S, Muenzner JK, Berral-Gonzalez A, Hampel C, Lindner P, Berninger A, Huebner K, Kunze P, Bäuerle T, Erlenbach-Wuensch K, Sánchez-Santos JM, Hartmann A, De Las Rivas J, Schneider-Stock R. A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer. Cancers (Basel). 2021 Dec 28;14(1). doi: 10.3390/cancers14010136. PMID: 35008299; PMCID: PMC8750372.
Copy Download .nbib Format: NLM
SIRT1 regulates Mxd1 during malignant melanoma progression.

Oncotarget

Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, Fahlbusch FB, Noushmehr H, Schneider-Stock R, Jasiulionis MG.
PMID: 29383100
Oncotarget. 2017 Oct 03;8(70):114540-114553. doi: 10.18632/oncotarget.21457. eCollection 2017 Dec 29.

In a murine melanoma model, malignant transformation promoted by a sustained stress condition was causally related to increased levels of reactive oxygen species resulting in DNA damage and massive epigenetic alterations. Since the chromatin modifier Sirtuin-1 (SIRT1) is a...

Cite
Meliso FM, Micali D, Silva CT, et al. SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget. 2017;8(70):114540-114553doi: 10.18632/oncotarget.21457.
Meliso, F. M., Micali, D., Silva, C. T., Sabedot, T. S., Coetzee, S. G., Koch, A., Fahlbusch, F. B., Noushmehr, H., Schneider-Stock, R., & Jasiulionis, M. G. (2017). SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget, 8(70), 114540-114553. https://doi.org/10.18632/oncotarget.21457
Meliso, Fabiana M, et al. "SIRT1 regulates Mxd1 during malignant melanoma progression." Oncotarget vol. 8,70 (2017): 114540-114553. doi: https://doi.org/10.18632/oncotarget.21457
Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, Fahlbusch FB, Noushmehr H, Schneider-Stock R, Jasiulionis MG. SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget. 2017 Oct 03;8(70):114540-114553. doi: 10.18632/oncotarget.21457. eCollection 2017 Dec 29. PMID: 29383100; PMCID: PMC5777712.
Copy Download .nbib Format: NLM
A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.

Cancers

Bueno-Fortes S, Muenzner JK, Berral-Gonzalez A, Hampel C, Lindner P, Berninger A, Huebner K, Kunze P, Bäuerle T, Erlenbach-Wuensch K, Sánchez-Santos JM, Hartmann A, De Las Rivas J, Schneider-Stock R.
PMID: 35008299
Cancers (Basel). 2021 Dec 28;14(1). doi: 10.3390/cancers14010136.

The epithelial-mesenchymal transition (EMT) is associated with tumor aggressiveness and increased invasion, migration, metastasis, angiogenesis, and drug resistance. Although the HCT116 p21-/- cell line is well known for its EMT-associated phenotype, with high Vimentin and low E-cadherin protein levels,...

Cite
Bueno-Fortes S, Muenzner JK, Berral-Gonzalez A, et al. A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010136.
Bueno-Fortes, S., Muenzner, J. K., Berral-Gonzalez, A., Hampel, C., Lindner, P., Berninger, A., Huebner, K., Kunze, P., Bäuerle, T., Erlenbach-Wuensch, K., Sánchez-Santos, J. M., Hartmann, A., De Las Rivas, J., & Schneider-Stock, R. (2021). A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer. Cancers, 14(1), . https://doi.org/10.3390/cancers14010136
Bueno-Fortes, Santiago, et al. "A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010136
Bueno-Fortes S, Muenzner JK, Berral-Gonzalez A, Hampel C, Lindner P, Berninger A, Huebner K, Kunze P, Bäuerle T, Erlenbach-Wuensch K, Sánchez-Santos JM, Hartmann A, De Las Rivas J, Schneider-Stock R. A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer. Cancers (Basel). 2021 Dec 28;14(1). doi: 10.3390/cancers14010136. PMID: 35008299.
Copy Download .nbib Format: NLM
miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients.

Neoplasia (New York, N.Y.)

da Cruz AT, Hunger A, de Melo FHM, Monteiro AC, Paré GC, Lai D, Alves-Fernandes DK, Ayub ALP, Cordero EM, Filho JFDS, Schneider-Stock R, Strauss BE, Tron V, Jasiulionis MG.
PMID: 34246986
Neoplasia. 2021 Aug;23(8):823-834. doi: 10.1016/j.neo.2021.05.015. Epub 2021 Jul 08.

Deregulation of miRNAs contributes to the development of distinct cancer types, including melanoma, an aggressive form of skin cancer characterized by high metastatic potential and poor prognosis. The expression of a set of 580 miRNAs was investigated in a...

Cite
da Cruz AT, Hunger A, de Melo FHM, et al. miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients. Neoplasia. 2021;23(8):823-834doi: 10.1016/j.neo.2021.05.015.
da Cruz, A. T., Hunger, A., de Melo, F. H. M., Monteiro, A. C., Paré, G. C., Lai, D., Alves-Fernandes, D. K., Ayub, A. L. P., Cordero, E. M., Filho, J. F. D. S., Schneider-Stock, R., Strauss, B. E., Tron, V., & Jasiulionis, M. G. (2021). miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients. Neoplasia (New York, N.Y.), 23(8), 823-834. https://doi.org/10.1016/j.neo.2021.05.015
da Cruz, Adriana Taveira, et al. "miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients." Neoplasia (New York, N.Y.) vol. 23,8 (2021): 823-834. doi: https://doi.org/10.1016/j.neo.2021.05.015
da Cruz AT, Hunger A, de Melo FHM, Monteiro AC, Paré GC, Lai D, Alves-Fernandes DK, Ayub ALP, Cordero EM, Filho JFDS, Schneider-Stock R, Strauss BE, Tron V, Jasiulionis MG. miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients. Neoplasia. 2021 Aug;23(8):823-834. doi: 10.1016/j.neo.2021.05.015. Epub 2021 Jul 08. PMID: 34246986; PMCID: PMC8274245.
Copy Download .nbib Format: NLM
Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells.

Oncotarget

Ivanovska J, Zlobec I, Forster S, Karamitopoulou E, Dawson H, Koelzer VH, Agaimy A, Garreis F, Söder S, Laqua W, Lugli A, Hartmann A, Rau TT, Schneider-Stock R.
PMID: 28407700
Oncotarget. 2017 Mar 14;8(11):18615-18616. doi: 10.18632/oncotarget.16154.

No abstract available.

Cite
Ivanovska J, Zlobec I, Forster S, et al. Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells. Oncotarget. 2017;8(11):18615-18616doi: 10.18632/oncotarget.16154.
Ivanovska, J., Zlobec, I., Forster, S., Karamitopoulou, E., Dawson, H., Koelzer, V. H., Agaimy, A., Garreis, F., Söder, S., Laqua, W., Lugli, A., Hartmann, A., Rau, T. T., & Schneider-Stock, R. (2017). Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells. Oncotarget, 8(11), 18615-18616. https://doi.org/10.18632/oncotarget.16154
Ivanovska, Jelena, et al. "Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells." Oncotarget vol. 8,11 (2017): 18615-18616. doi: https://doi.org/10.18632/oncotarget.16154
Ivanovska J, Zlobec I, Forster S, Karamitopoulou E, Dawson H, Koelzer VH, Agaimy A, Garreis F, Söder S, Laqua W, Lugli A, Hartmann A, Rau TT, Schneider-Stock R. Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells. Oncotarget. 2017 Mar 14;8(11):18615-18616. doi: 10.18632/oncotarget.16154. PMID: 28407700; PMCID: PMC5392353.
Copy Download .nbib Format: NLM
Withdrawal. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.

Endocrine

Boltze C, Lehnert H, Schneider-Stock R, Peters B, Hoang Vu C, Roessner A.
PMID: 15218884
Endocrine. 2004 Mar-Apr;23(2):229. doi: 10.1007/s12020-004-0002-4.

No abstract available.

Cite
Boltze C, Lehnert H, Schneider-Stock R, et al. Withdrawal. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma. Endocrine. 2004;23(2):229doi: 10.1007/s12020-004-0002-4.
Boltze, C., Lehnert, H., Schneider-Stock, R., Peters, B., Hoang Vu, C., & Roessner, A. (2004). Withdrawal. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma. Endocrine, 23(2), 229. https://doi.org/10.1007/s12020-004-0002-4
Boltze, C, et al. "Withdrawal. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma." Endocrine vol. 23,2 (2004): 229. doi: https://doi.org/10.1007/s12020-004-0002-4
Boltze C, Lehnert H, Schneider-Stock R, Peters B, Hoang Vu C, Roessner A. Withdrawal. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma. Endocrine. 2004 Mar-Apr;23(2):229. doi: 10.1007/s12020-004-0002-4. PMID: 15218884.
Copy Download .nbib Format: NLM
Overview of major classes of plant-derived anticancer drugs.

International journal of biomedical science : IJBS

Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R.
PMID: 23675107
Int J Biomed Sci. 2009 Mar;5(1):1-11.

Cancer is the second leading cause of death worldwide. Conventional cancer therapies cause serious side effects and, at best, merely extend the patient's lifespan by a few years. Cancer control may therefore benefit from the potential that resides in...

Cite
Amin A, Gali-Muhtasib H, Ocker M, et al. Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci. 2009;5(1):1-11
Amin, A., Gali-Muhtasib, H., Ocker, M., & Schneider-Stock, R. (2009). Overview of major classes of plant-derived anticancer drugs. International journal of biomedical science : IJBS, 5(1), 1-11.
Amin, Amr, et al. "Overview of major classes of plant-derived anticancer drugs." International journal of biomedical science : IJBS vol. 5,1 (2009): 1-11.
Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R. Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci. 2009 Mar;5(1):1-11. PMID: 23675107; PMCID: PMC3614754.
Copy Download .nbib Format: NLM
Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes.

International journal of molecular sciences

Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, Schneider-Stock R, Geppert CI.
PMID: 34884913
Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313108.

Peritumoral budding and intratumoral budding (ITB) are important prognostic factors for colorectal cancer patients. Scientists worldwide have investigated the role of budding in tumor progression and its prognosis, but guidelines for reliably identifying tumor buds based on morphology are...

Cite
Pour Farid P, Eckstein M, Merkel S, et al. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313108.
Pour Farid, P., Eckstein, M., Merkel, S., Grützmann, R., Hartmann, A., Bruns, V., Benz, M., Schneider-Stock, R., & Geppert, C. I. (2021). Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313108
Pour Farid, Pantea, et al. "Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313108
Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, Schneider-Stock R, Geppert CI. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313108. PMID: 34884913; PMCID: PMC8658236.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries